Immuneering Corp — Director's Dealing 2022

Feb 10, 2022

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2021-12-31

Reporting Person: Zeskind Benjamin J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-22	Class A Common Stock	G	350000	—	Disposed	2252352	Direct
2021-10-22	Class A Common Stock	G	350000	—	Acquired	894927	Indirect

Footnotes

F1: Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.